ARYX — Aryx Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Aryx Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2005 December 31st	2006 December 31st	2007 December 31st	C2008 December 31st	2009 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	26.3	50.3	63.1	44.6	7.76
Net Total Accounts Receivable
Net Total Receivables	0	0.045	—	—	—
Prepaid Expenses
Total Other Current Assets
Total Current Assets	27.7	51.4	64.9	45.9	8.81
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	4.14	4.17	3.65	3.2	2.26
Other Long Term Assets
Total Assets	33.3	56.8	69.6	51.1	12.4
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	7.75	11.5	13.5	11	8.68
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	19	39.8	34.3	23.7	15.3
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	14.3	17	35.3	27.4	-2.92
Total Liabilities & Shareholders' Equity	33.3	56.8	69.6	51.1	12.4
Total Common Shares Outstanding